Ftse Mib
33.707,21
-0,38%
DAX
18.177,62
-0,90%
S&P 500
5.469,30
0,39%
NASDAQ
17.717,65
1,26%
Bitcoin
61.982,68
0,29%
Registration Strip Icon for alerts Registrati per avvisi in tempo reale, portafoglio personalizzato e movimenti di mercato.
Registrati

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ Biodesix Inc (BDSX) Biodesix Inc (BDSX) Notizie

BDSX

Biodesix (BDSX)

HOME News News di Agenzia

News di Agenzia

Da:
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NASDAQ:BDSX
DataOraFonteTitoloSimboloCompagnia
18/06/202414:13Business WireBiodesix Named to Inc. Magazine’s 2024 “Best Workplaces”NASDAQ:BDSXBiodesix Inc
05/06/202422:08Edgar (US Regulatory)Form 424B3 - Prospectus [Rule 424(b)(3)]NASDAQ:BDSXBiodesix Inc
05/06/202406:15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:BDSXBiodesix Inc
28/05/202412:00Business WireBiodesix to Participate in Two Investor Conferences in JuneNASDAQ:BDSXBiodesix Inc
24/05/202422:11Edgar (US Regulatory)Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]NASDAQ:BDSXBiodesix Inc
24/05/202401:15Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:BDSXBiodesix Inc
24/05/202401:09Edgar (US Regulatory)Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]NASDAQ:BDSXBiodesix Inc
21/05/202412:00Business WireBiodesix to Present New Data on the Nodify XL2® Test at ATS 2024 Annual MeetingNASDAQ:BDSXBiodesix Inc
09/05/202422:07Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:BDSXBiodesix Inc
08/05/202422:10Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:BDSXBiodesix Inc
08/05/202422:05Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:BDSXBiodesix Inc
08/05/202422:01Business WireBiodesix Announces First Quarter 2024 Results Driven by Growth in Lung Diagnostic Testing for Lung Nodule ManagementNASDAQ:BDSXBiodesix Inc
07/05/202412:00Business WireBiodesix to Participate in the 2024 RBCCM Global Healthcare ConferenceNASDAQ:BDSXBiodesix Inc
24/04/202412:00Business WireBiodesix to Report First Quarter 2024 Financial Results on May 8, 2024NASDAQ:BDSXBiodesix Inc
09/04/202423:00Business WireBiodesix to Present New Data on Liquid Biopsy Technologies at AACR 2024 Annual MeetingNASDAQ:BDSXBiodesix Inc
05/04/202413:17Business WireBiodesix Announces Pricing of Oversubscribed and Upsized Underwritten Offering of Common Stock and Concurrent Private PlacementNASDAQ:BDSXBiodesix Inc
25/03/202411:00Business WireBiodesix Announces New Master Collaborative Research Agreement with Leading US Cancer CenterNASDAQ:BDSXBiodesix Inc
01/03/202412:11Edgar (US Regulatory)Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]NASDAQ:BDSXBiodesix Inc
01/03/202412:00Business WireBiodesix Announces Fourth Quarter and Fiscal Year 2023 Results and Business HighlightsNASDAQ:BDSXBiodesix Inc
26/02/202412:00Business WireBiodesix to Participate in the TD Cowen 44th Annual Health Care ConferenceNASDAQ:BDSXBiodesix Inc
16/02/202412:00Business WireBiodesix to Report Fourth Quarter and Full Year 2023 Financial Results on March 1, 2024NASDAQ:BDSXBiodesix Inc
02/02/202422:09Edgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNASDAQ:BDSXBiodesix Inc
14/11/202312:00Business WireBiodesix Enhances Access to Nodify Lung® Testing with Launch of New Blood Draw MethodNASDAQ:BDSXBiodesix Inc
09/11/202312:00Business WireBiodesix to Participate in Two Upcoming Investor Conferences in NovemberNASDAQ:BDSXBiodesix Inc
07/11/202322:01Business Wire Biodesix Announces Third Quarter 2023 Results and HighlightsNASDAQ:BDSXBiodesix Inc
24/10/202312:00Business WireBiodesix to Report Third Quarter 2023 Financial Results on November 7, 2023NASDAQ:BDSXBiodesix Inc
03/10/202312:00Business WireBiodesix to Present New Data on Nodify Lung® Testing at CHEST 2023 Annual MeetingNASDAQ:BDSXBiodesix Inc
07/09/202312:00Business WireBiodesix Announces Two Presentations on Lung Cancer Treatment Guidance Tests at the IASLC 2023 World Lung Conference on Lung CancerNASDAQ:BDSXBiodesix Inc
05/09/202312:00Business WireBiodesix to Participate in Two Upcoming Investor Conferences in SeptemberNASDAQ:BDSXBiodesix Inc
22/08/202312:00Business WireBiodesix Announces Presentation of New Nodify XL2® Data at AABIP Conference Highlighting Increased Proportion of Biopsies Diagnosing CancerNASDAQ:BDSXBiodesix Inc
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NASDAQ:BDSX

La tua Cronologia

LSE
GCAP
Gcap Media
USOTC
RCJTS
RSE Collection (GM)
LSE
96QZ
Metro.tokyo 23u
Delayed Upgrade Clock
Per accedere al tempo reale push di Borsa è necessario registrarsi.

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' SUL SITO CLICCARE QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network